This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

ANN INC. Rallies In Support Of The Fight Against Breast Cancer With Launch Of Annual Giving Campaign

NEW YORK, Oct. 1, 2013 /PRNewswire/ -- ANN INC. (NYSE: ANN), the parent Company of Ann Taylor and LOFT, today reaffirms its dedicated support of The Breast Cancer Research Foundation (BCRF) through its annual Breast Cancer Awareness campaign and new in-store and online promotions. Since 2005, the Company has donated $14 million to BCRF. Last year alone the company donated a record breaking $4 million which will fully fund sixteen pioneering BCRF research grants this year in the United States and Canada.

(Photo: http://photos.prnewswire.com/prnh/20131001/NY85830-a )(Photo: http://photos.prnewswire.com/prnh/20131001/NY85830-b )

"Breast cancer touches the lives of so many, and as a Company that inspires and connects with women to put their best selves forward – including the tens of thousands of women we work with around the world – we are proud to  support vital breast cancer research through our dedicated efforts with The Breast Cancer Research Foundation," said Kay Krill, President and CEO of ANN INC. "Our breast cancer awareness campaign will allow us to collectively make a profound impact and positive difference for all women and families impacted by this disease." 

In recognition of National Breast Cancer Awareness Month in October, ANN INC. is proud to support BCRF with the sale of Ann Taylor Cares and LOFT Cares Cards. Through this unique program, the Company has fully funded sixteen leading-edge research projects for the 2013-2014 grant period. Led by distinguished investigators from prominent institutions across the country, the project topics span from the use of novel drugs targeting white blood cells to develop new breast cancer therapies to the identification of ways to thwart the growth of breast tumors – and many others. ANN INC. has funded BCRF research projects for 8 years and is proud to expand its support to sixteen grantees this year.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,678.98 -97.14 -0.55%
S&P 500 2,057.72 -10.17 -0.49%
NASDAQ 4,862.8560 -38.0290 -0.78%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs